Top videos
Achalasia is a neurogenic esophageal motility disorder characterized by impaired esophageal peristalsis and a lack of lower esophageal sphincter relaxation during swallowing. Symptoms are slowly progressive dysphagia, usually to both liquids and solids, and regurgitation of undigested food. Evaluation typically includes manometry, barium swallow, and endoscopy. Treatments include dilation, chemical denervation, surgical myotomy, and peroral endoscopic myotomy.
Prompted by the hormone prolactin, the alveoli take proteins, sugars, and fat from your blood supply and make breast milk. A network of cells surrounding the alveoli squeeze the glands and push the milk out into the ductules, which lead to a bigger duct.
So you want to be a cardiothoracic surgeon. You like the idea of open heart surgery and the glory that comes with being a CT surgeon. Let’s debunk the public perception myths of what it means to be a cardiothoracic surgeon, and give it to you straight. This is the reality of cardiothoracic surgery.
✒️ Accompanying Blog Post: https://medschoolinsiders.com/....medical-student/so-y
💌 Sign up for my weekly newsletter - https://medschoolinsiders.com/newsletter
🌍 Website & blog - https://medschoolinsiders.com
📸 Instagram - https://instagram.com/medschoolinsiders
🐦 Twitter - https://twitter.com/medinsiders
🗣️ Facebook - https://facebook.com/medschoolinsiders
🎥 My Youtube Gear: https://kit.co/kevinjubbalmd/
👀 Hand Picked Productivity Tools: https://www.amazon.com/shop/medschoolinsiders
🎵My Study Playlist: https://open.spotify.com/user/....1231934998/playlist/
TIME STAMPS:
00:41 - What is Cardiothoracic Surgery?
04:08 - How to Become a Cardiothoracic Surgeon
06:29 - Subspecialties within Cardiothoracic Surgery
07:49 - What You’ll Love About Cardiothoracic Surgery
09:10 - What You Won’t Love About Cardiothoracic Surgery
10:04 - Should You Become a Cardiothoracic Surgeon?
LINKS FROM VIDEO:
So You Want to Be Playlist: https://www.youtube.com/playli....st?list=PL2ADAFpTg5a
Day in the Life Playlist: https://www.youtube.com/playli....st?list=PLTCN43UFAlB
#medicalschool #cardiothoracicsurgery #soyouwanttobe
====================
Disclaimer: Content of this video is my opinion and does not constitute medical advice. The content and associated links provide general information for general educational purposes only. Use of this information is strictly at your own risk. Kevin Jubbal, M.D. and Med School Insiders LLC will not assume any liability for direct or indirect losses or damages that may result from the use of information contained in this video including but not limited to economic loss, injury, illness or death. May include affiliate links to Amazon. As an Amazon Associate, I may earn a commission on qualifying purchases made through them (at no extra cost to you).
Current treatment is a combination of pegylated interferon-alpha-2a or pegylated interferon-alpha-2b (brand names Pegasys or PEG-Intron) and the antiviral drug ribavirin for a period of 24 or 48 weeks, depending on hepatitis C virus genotype. In a large multicenter randomized control study among genotype 2 or 3 infected patients (NORDymanIC),[35] patients achieving HCV RNA below 1000 IU/mL by day 7 who were treated for 12 weeks demonstrated similar cure rates as those treated for 24 weeks.[36][37]
Pegylated interferon-alpha-2a plus ribavirin may increase sustained virological response among patients with chronic hepatitis C as compared to pegylated interferon-alpha-2b plus ribavirin according to a systematic review of randomized controlled trials .[38] The relative benefit increase was 14.6%. For patients at similar risk to those in this study (41.0% had sustained virological response when not treated with pegylated interferon alpha 2a plus ribavirin), this leads to an absolute benefit increase of 6%. About 16.7 patients must be treated for one to benefit (number needed to treat = 16.7; click here [39] to adjust these results for patients at higher or lower risk of sustained virological response). However, this study's results may be biased due to uncertain temporality of association, selective dose response.
Treatment is generally recommended for patients with proven hepatitis C virus infection and persistently abnormal liver function tests.
Treatment during the acute infection phase has much higher success rates (greater than 90%) with a shorter duration of treatment; however, this must be balanced against the 15-40% chance of spontaneous clearance without treatment (see Acute Hepatitis C section above).
Those with low initial viral loads respond much better to treatment than those with higher viral loads (greater than 400,000 IU/mL). Current combination therapy is usually supervised by physicians in the fields of gastroenterology, hepatology or infectious disease.
The treatment may be physically demanding, particularly for those with a prior history of drug or alcohol abuse. It can qualify for temporary disability in some cases. A substantial proportion of patients will experience a panoply of side effects ranging from a 'flu-like' syndrome (the most common, experienced for a few days after the weekly injection of interferon) to severe adverse events including anemia, cardiovascular events and psychiatric problems such as suicide or suicidal ideation. The latter are exacerbated by the general physiological stress experienced by the patient.
While an anal abscess is an infection within one or more of the anal spaces, an anal fistula (Choice B) is a tunneling between the anus or rectum and another epithelial lined space (eg, the skin overlying the drainage site). Fifty percent of patients with anal abscesses will go on to develop a chronic fistula from the involved anal gland to the overlying skin. Patients with fistulas typically present with an anal abscess that persists after incision and drainage, or with a pustule-like lesion in the perianal or ischiorectal area that continually drains. Surgical repair is usually necessary to eliminate the fistula while preserving fecal continence.
Smallpox disease is a serious, highly contagious, and often life-threatening infection marked by a rash of round pox (blisters) on the face, arms, and legs. It is caused by the Variola virus. The last case of smallpox in the United States was in 1949.
Simple microinstruments and a medical school laboratory microscope were used for anastomosis training. Chicken blood vessels were used as a material for this study. A long segment of blood vessel from the proximal brachial artery to the distal radial artery was used for training. End-to-side anastomosis was practiced first, and the training continued with end-to-end anastomosis of the appropriate segments.